Skip to main content
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1998 Aug;63(2):390–398. doi: 10.1086/301948

A point mutation in an intronic branch site results in aberrant splicing of COL5A1 and in Ehlers-Danlos syndrome type II in two British families.

N P Burrows 1, A C Nicholls 1, A J Richards 1, C Luccarini 1, J B Harrison 1, J R Yates 1, F M Pope 1
PMCID: PMC1377290  PMID: 9683580

Abstract

Ehlers-Danlos syndrome (EDS) is a heterogeneous group of connective-tissue disorders characterized by skin fragility, joint laxity, and skeletal deformities. Type V collagen appears to have a causal role in EDS types I and II, which show phenotypic overlap and may sometimes be allelic. Type V collagen can exist as a heterotrimer, [alpha1(V)]2alpha2(V), and it both coassembles with and regulates type I collagen-fibril diameter. Using an intragenic COL5A1 polymorphism, we have demonstrated linkage, at zero recombination, to the same allele in two large British EDS type II families (LOD scores 4.1 and 4.3). Affected members from each family were heterozygous for a point mutation in intron 32 (IVS32:T-25G), causing the 45-bp exon 33 to be lost from the mRNA in approximately 60% of transcripts from the mutant gene. This mutation lies only 2 bp upstream of a highly conserved adenosine in the consensus branch-site sequence, which is required for lariat formation. Although both families shared the same marker allele, we have been unable to identify a common genealogy. This is the first description of a mutation at the lariat branch site, which plays a pivotal role in the splicing mechanism, in a collagen gene. Very probably, the resulting in-frame exon skip has a dominant-negative effect due to incorporation of the mutant proalpha chain into the triple-helical molecule. These findings further confirm the importance of type V collagen in the causation of EDS type II, and the novel collagen mutation indicates the importance of the lariat branch site in splicing.

Full Text

The Full Text of this article is available as a PDF (3.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrikopoulos K., Liu X., Keene D. R., Jaenisch R., Ramirez F. Targeted mutation in the col5a2 gene reveals a regulatory role for type V collagen during matrix assembly. Nat Genet. 1995 Jan;9(1):31–36. doi: 10.1038/ng0195-31. [DOI] [PubMed] [Google Scholar]
  2. Beighton P., Solomon L., Soskolne C. L. Articular mobility in an African population. Ann Rheum Dis. 1973 Sep;32(5):413–418. doi: 10.1136/ard.32.5.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beighton P., de Paepe A., Danks D., Finidori G., Gedde-Dahl T., Goodman R., Hall J. G., Hollister D. W., Horton W., McKusick V. A. International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986. Am J Med Genet. 1988 Mar;29(3):581–594. doi: 10.1002/ajmg.1320290316. [DOI] [PubMed] [Google Scholar]
  4. Birk D. E., Fitch J. M., Babiarz J. P., Doane K. J., Linsenmayer T. F. Collagen fibrillogenesis in vitro: interaction of types I and V collagen regulates fibril diameter. J Cell Sci. 1990 Apr;95(Pt 4):649–657. doi: 10.1242/jcs.95.4.649. [DOI] [PubMed] [Google Scholar]
  5. Burrows N. P., Nicholls A. C., Yates J. R., Gatward G., Sarathachandra P., Richards A., Pope F. M. The gene encoding collagen alpha1(V)(COL5A1) is linked to mixed Ehlers-Danlos syndrome type I/II. J Invest Dermatol. 1996 Jun;106(6):1273–1276. doi: 10.1111/1523-1747.ep12348978. [DOI] [PubMed] [Google Scholar]
  6. De Paepe A., Nuytinck L., Hausser I., Anton-Lamprecht I., Naeyaert J. M. Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II. Am J Hum Genet. 1997 Mar;60(3):547–554. [PMC free article] [PubMed] [Google Scholar]
  7. Emanuel B. S., Cannizzaro L. A., Seyer J. M., Myers J. C. Human alpha 1(III) and alpha 2(V) procollagen genes are located on the long arm of chromosome 2. Proc Natl Acad Sci U S A. 1985 May;82(10):3385–3389. doi: 10.1073/pnas.82.10.3385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fichard A., Kleman J. P., Ruggiero F. Another look at collagen V and XI molecules. Matrix Biol. 1995 Jul;14(7):515–531. doi: 10.1016/s0945-053x(05)80001-0. [DOI] [PubMed] [Google Scholar]
  9. Greenspan D. S., Byers M. G., Eddy R. L., Cheng W., Jani-Sait S., Shows T. B. Human collagen gene COL5A1 maps to the q34.2----q34.3 region of chromosome 9, near the locus for nail-patella syndrome. Genomics. 1992 Apr;12(4):836–837. doi: 10.1016/0888-7543(92)90320-r. [DOI] [PubMed] [Google Scholar]
  10. Greenspan D. S., Cheng W., Hoffman G. G. The pro-alpha 1(V) collagen chain. Complete primary structure, distribution of expression, and comparison with the pro-alpha 1(XI) collagen chain. J Biol Chem. 1991 Dec 25;266(36):24727–24733. [PubMed] [Google Scholar]
  11. Greenspan D. S., Northrup H., Au K. S., McAllister K. A., Francomano C. A., Wenstrup R. J., Marchuk D. A., Kwiatkowski D. J. COL5A1: fine genetic mapping and exclusion as candidate gene in families with nail-patella syndrome, tuberous sclerosis 1, hereditary hemorrhagic telangiectasia, and Ehlers-Danlos Syndrome type II. Genomics. 1995 Feb 10;25(3):737–739. doi: 10.1016/0888-7543(95)80021-d. [DOI] [PubMed] [Google Scholar]
  12. Kuivenhoven J. A., Weibusch H., Pritchard P. H., Funke H., Benne R., Assmann G., Kastelein J. J. An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease). J Clin Invest. 1996 Jul 15;98(2):358–364. doi: 10.1172/JCI118800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Linsenmayer T. F., Gibney E., Igoe F., Gordon M. K., Fitch J. M., Fessler L. I., Birk D. E. Type V collagen: molecular structure and fibrillar organization of the chicken alpha 1(V) NH2-terminal domain, a putative regulator of corneal fibrillogenesis. J Cell Biol. 1993 Jun;121(5):1181–1189. doi: 10.1083/jcb.121.5.1181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Loughlin J., Irven C., Hardwick L. J., Butcher S., Walsh S., Wordsworth P., Sykes B. Linkage of the gene that encodes the alpha 1 chain of type V collagen (COL5A1) to type II Ehlers-Danlos syndrome (EDS II). Hum Mol Genet. 1995 Sep;4(9):1649–1651. doi: 10.1093/hmg/4.9.1649. [DOI] [PubMed] [Google Scholar]
  15. Maquat L. E. Defects in RNA splicing and the consequence of shortened translational reading frames. Am J Hum Genet. 1996 Aug;59(2):279–286. [PMC free article] [PubMed] [Google Scholar]
  16. Marchant J. K., Hahn R. A., Linsenmayer T. F., Birk D. E. Reduction of type V collagen using a dominant-negative strategy alters the regulation of fibrillogenesis and results in the loss of corneal-specific fibril morphology. J Cell Biol. 1996 Dec;135(5):1415–1426. doi: 10.1083/jcb.135.5.1415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nicholls A. C., Oliver J. E., McCarron S., Harrison J. B., Greenspan D. S., Pope F. M. An exon skipping mutation of a type V collagen gene (COL5A1) in Ehlers-Danlos syndrome. J Med Genet. 1996 Nov;33(11):940–946. doi: 10.1136/jmg.33.11.940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ott J. Estimation of the recombination fraction in human pedigrees: efficient computation of the likelihood for human linkage studies. Am J Hum Genet. 1974 Sep;26(5):588–597. [PMC free article] [PubMed] [Google Scholar]
  19. Pope F. M., Burrows N. P. Ehlers-Danlos syndrome has varied molecular mechanisms. J Med Genet. 1997 May;34(5):400–410. doi: 10.1136/jmg.34.5.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Query C. C., Moore M. J., Sharp P. A. Branch nucleophile selection in pre-mRNA splicing: evidence for the bulged duplex model. Genes Dev. 1994 Mar 1;8(5):587–597. doi: 10.1101/gad.8.5.587. [DOI] [PubMed] [Google Scholar]
  21. Reed R., Maniatis T. The role of the mammalian branchpoint sequence in pre-mRNA splicing. Genes Dev. 1988 Oct;2(10):1268–1276. doi: 10.1101/gad.2.10.1268. [DOI] [PubMed] [Google Scholar]
  22. Sage H., Bornstein P. Characterization of a novel collagen chain in human placenta and its relation to AB collagen. Biochemistry. 1979 Aug 21;18(17):3815–3822. doi: 10.1021/bi00584a027. [DOI] [PubMed] [Google Scholar]
  23. Takahara K., Hoffman G. G., Greenspan D. S. Complete structural organization of the human alpha 1 (V) collagen gene (COL5A1): divergence from the conserved organization of other characterized fibrillar collagen genes. Genomics. 1995 Oct 10;29(3):588–597. doi: 10.1006/geno.1995.9961. [DOI] [PubMed] [Google Scholar]
  24. Toriello H. V., Glover T. W., Takahara K., Byers P. H., Miller D. E., Higgins J. V., Greenspan D. S. A translocation interrupts the COL5A1 gene in a patient with Ehlers-Danlos syndrome and hypomelanosis of Ito. Nat Genet. 1996 Jul;13(3):361–365. doi: 10.1038/ng0796-361. [DOI] [PubMed] [Google Scholar]
  25. Wenstrup R. J., Langland G. T., Willing M. C., D'Souza V. N., Cole W. G. A splice-junction mutation in the region of COL5A1 that codes for the carboxyl propeptide of pro alpha 1(V) chains results in the gravis form of the Ehlers-Danlos syndrome (type I). Hum Mol Genet. 1996 Nov;5(11):1733–1736. doi: 10.1093/hmg/5.11.1733. [DOI] [PubMed] [Google Scholar]
  26. Wu J., Manley J. L. Mammalian pre-mRNA branch site selection by U2 snRNP involves base pairing. Genes Dev. 1989 Oct;3(10):1553–1561. doi: 10.1101/gad.3.10.1553. [DOI] [PubMed] [Google Scholar]
  27. Zhuang Y. A., Goldstein A. M., Weiner A. M. UACUAAC is the preferred branch site for mammalian mRNA splicing. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2752–2756. doi: 10.1073/pnas.86.8.2752. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES